| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Michael Detmar | Q64867609 |
| P2093 | author name string | Sinem Karaman | |
| P2860 | cites work | Lymphangiogenesis and cancer metastasis | Q84190566 |
| VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics | Q84621185 | ||
| Dynamics of lymphatic regeneration and flow patterns after lymph node dissection | Q86647272 | ||
| LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan | Q22008808 | ||
| Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
| VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development | Q24316025 | ||
| Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors | Q24675750 | ||
| Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis | Q27311384 | ||
| Do all roads lead to Rome? Routes to metastasis development | Q27692533 | ||
| VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 | ||
| Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis | Q28200101 | ||
| LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis | Q28207071 | ||
| Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation | Q28285842 | ||
| Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis | Q28587821 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells | Q30415907 | ||
| Lymphatic endothelial cells - key players in regulation of tolerance and immunity | Q30424567 | ||
| Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation | Q30434547 | ||
| Sentinel node mapping for breast cancer: current situation | Q30464471 | ||
| Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? | Q77794181 | ||
| Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes | Q79767236 | ||
| Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node | Q81310337 | ||
| Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action | Q82312177 | ||
| Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis | Q82588722 | ||
| Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis | Q82719711 | ||
| Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT | Q83366232 | ||
| Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis | Q83817384 | ||
| Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse | Q30499924 | ||
| Mechanoinduction of lymph vessel expansion | Q30505376 | ||
| Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update | Q30524322 | ||
| Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis | Q30539614 | ||
| Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. | Q30541916 | ||
| An in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis | Q33455334 | ||
| Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases | Q33535173 | ||
| Hepatocyte growth factor promotes lymphatic vessel formation and function | Q33919993 | ||
| Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes | Q33986146 | ||
| B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization | Q33993521 | ||
| The lymphatic system in health and disease | Q34015299 | ||
| Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. | Q34066152 | ||
| Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo | Q34098683 | ||
| Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation | Q34161479 | ||
| Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. | Q34251293 | ||
| PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis | Q34359534 | ||
| Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis | Q34403458 | ||
| Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. | Q34455428 | ||
| Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium | Q34502407 | ||
| Metastatic pathways and time courses in the orderly progression of cutaneous melanoma | Q34524987 | ||
| An important role of lymphatic vessel activation in limiting acute inflammation | Q34997755 | ||
| Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice | Q35146135 | ||
| Insights into the mechanisms of lymph node metastasis | Q35181938 | ||
| VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites | Q35616124 | ||
| Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis | Q35750191 | ||
| Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival | Q35791518 | ||
| Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis | Q35842980 | ||
| Inflammation-induced lymph node lymphangiogenesis is reversible | Q35952004 | ||
| In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography | Q36098586 | ||
| Quantitative imaging of lymphatic function with liposomal indocyanine green | Q36098607 | ||
| Lymphangiogenesis and cancer | Q36137692 | ||
| VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes | Q36384880 | ||
| VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis | Q36403416 | ||
| Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis | Q36534347 | ||
| Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer | Q36611984 | ||
| First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours | Q36612618 | ||
| An important role of blood and lymphatic vessels in inflammation and allergy | Q36616466 | ||
| Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours | Q36617968 | ||
| Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo. | Q37020622 | ||
| Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma | Q37404735 | ||
| Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease | Q37413735 | ||
| Dose-dependent response of FGF-2 for lymphangiogenesis | Q37415307 | ||
| Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage | Q37635188 | ||
| Lymphangiogenesis: Molecular mechanisms and future promise | Q37697245 | ||
| Interaction of tumor cells and lymphatic vessels in cancer progression | Q37969667 | ||
| Molecular mechanisms and imaging of lymphatic metastasis | Q38090228 | ||
| Mechanical forces in lymphatic vascular development and disease | Q38105904 | ||
| The inflammatory response of lymphatic endothelium | Q38155100 | ||
| Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. | Q38457507 | ||
| Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo | Q39081980 | ||
| Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1. | Q39221390 | ||
| Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. | Q39722616 | ||
| Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications | Q40243316 | ||
| Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels | Q40414498 | ||
| The crucial role of macrophages in lymphangiogenesis | Q41945366 | ||
| B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis | Q42086633 | ||
| Transmural flow modulates cell and fluid transport functions of lymphatic endothelium | Q42466882 | ||
| CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche | Q42833135 | ||
| Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism | Q46119200 | ||
| Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. | Q46989487 | ||
| Sentinel lymph node pressure in breast cancer | Q50276883 | ||
| VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis. | Q50972973 | ||
| Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery. | Q53109783 | ||
| In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography. | Q53124507 | ||
| Tissue Fluid Pressure and Flow during Pneumatic Compression in Lymphedema of Lower Limbs | Q56779996 | ||
| Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer Cells Prevents Metastasis | Q57381940 | ||
| Preexisting Lymphatic Endothelium but not Endothelial Progenitor Cells Are Essential for Tumor Lymphangiogenesis and Lymphatic Metastasis | Q57382127 | ||
| Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 | ||
| Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping | Q57912046 | ||
| A Novel Gene Expression Profile in Lymphatics Associated with Tumor Growth and Nodal Metastasis | Q58807977 | ||
| Prox1 function is required for the development of the murine lymphatic system | Q73025820 | ||
| Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma | Q77137462 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 922-928 | |
| P577 | publication date | 2014-03-03 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Mechanisms of lymphatic metastasis | |
| P478 | volume | 124 |
| Q89432062 | 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model |
| Q57472094 | 3.0 T relaxation time measurements of human lymph nodes in adults with and without lymphatic insufficiency: Implications for magnetic resonance lymphatic imaging |
| Q87057698 | A Lanthanum-Tagged Chemotherapeutic Agent HA-Pt to Track the In Vivo Distribution of Hyaluronic Acid Complexes |
| Q35695806 | A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities |
| Q35691781 | ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells. |
| Q92628370 | Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis |
| Q90617444 | Anatomy and function of the vertebral column lymphatic network in mice |
| Q28070234 | Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems |
| Q49964473 | Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer. |
| Q58697956 | CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression |
| Q89606417 | CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers |
| Q47889283 | CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas |
| Q89543001 | Cancer initiation and progression within the cancer microenvironment |
| Q64932940 | Cell-penetrating peptide-based nanovehicles potentiate lymph metastasis targeting and deep penetration for anti-metastasis therapy. |
| Q90854590 | Cellular traffic through afferent lymphatic vessels |
| Q64276040 | Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression |
| Q26747723 | Clinical utilities and biological characteristics of melanoma sentinel lymph nodes |
| Q35042182 | Culture medium of bone marrow-derived human mesenchymal stem cells effects lymphatic endothelial cells and tumor lymph vessel formation |
| Q91123454 | DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression |
| Q37362656 | DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma |
| Q38769721 | DeepCAGE transcriptomics identify HOXD10 as a transcription factor regulating lymphatic endothelial responses to VEGF-C. |
| Q89689621 | Development of a novel murine model of lymphatic metastasis |
| Q42475320 | Development of full-thickness human skin equivalents with blood and lymph-like capillary networks by cell coating technology |
| Q40073882 | Development of the LYVE-1 Gene with An Acidic-amino-acid-rich (AAAR) Domain in Evolution Is Associated with Acquisition of Lymph Nodes and Efficient Adaptive Immunity. |
| Q38811974 | Dimethylfumarate effectively inhibits lymphangiogenesis via p21 induction and G1 cell cycle arrest |
| Q50517451 | Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients. |
| Q39130446 | Emerging Biological Principles of Metastasis |
| Q91938707 | Excretable Lanthanide Nanoparticle for Biomedical Imaging and Surgical Navigation in the Second Near-Infrared Window |
| Q90589793 | Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer |
| Q93195005 | Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties |
| Q37042262 | Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivation |
| Q89994640 | Future Needs in Mast Cell Biology |
| Q57175019 | Future perspectives: cancer metastases |
| Q58698791 | Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer |
| Q35962330 | Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma |
| Q89375164 | Glove and instrument changing to prevent tumour seeding in cancer surgery: a survey of surgeons' beliefs and practices |
| Q58709934 | Heterogeneity of tumor lymphangiogenesis: Progress and prospects |
| Q90100620 | Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes |
| Q36014824 | Human lymphatic endothelial cells contribute to epithelial ovarian carcinoma metastasis by promoting lymphangiogenesis and tumour cell invasion |
| Q99548748 | Immune Organs and Immune Cells on a Chip: An Overview of Biomedical Applications |
| Q58123958 | Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury |
| Q38307997 | Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity. |
| Q34926262 | In vivo albumin labeling and lymphatic imaging |
| Q36994123 | Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle |
| Q27301422 | Intravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis |
| Q49884430 | Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis |
| Q39079697 | Low-molecular-weight hyaluronan (LMW-HA) accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion |
| Q57490822 | Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells? |
| Q39063008 | Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses |
| Q26825144 | Lymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axis |
| Q47744569 | Lymphangiogenesis guidance by paracrine and pericellular factors |
| Q38254023 | Lymphangiogenesis in renal diseases: passive bystander or active participant? |
| Q90482453 | Lymphatic Vessel Network Structure and Physiology |
| Q89867222 | Lymphatic endothelial cells of the lymph node |
| Q35475925 | Lymphatic imaging: focus on imaging probes |
| Q90730874 | Lymphatic outflow of cerebrospinal fluid is reduced in glioma |
| Q91980576 | Lymphatic vasculature in tumor metastasis and immunobiology |
| Q37217526 | Lymphatic vessels regulate immune microenvironments in human and murine melanoma |
| Q48185155 | Lymphedema evaluation using noninvasive 3T MR lymphangiography. |
| Q37681087 | Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy. |
| Q64114248 | Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer |
| Q37541860 | Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging |
| Q52339904 | Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes. |
| Q26801136 | Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer |
| Q50088515 | Metastasis of cancer: when and how? |
| Q28273264 | MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells |
| Q50235940 | Microneedles for the Noninvasive Structural and Functional Assessment of Dermal Lymphatic Vessels |
| Q30836624 | Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay |
| Q57802920 | Molecular Mechanisms of Long Noncoding RNAs-medicated Cancer Metastasis |
| Q88796727 | Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer |
| Q28072045 | New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy |
| Q40990861 | New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network |
| Q90734648 | Non-coding RNAs as Regulators of Lymphangiogenesis in Lymphatic Development, Inflammation, and Cancer Metastasis |
| Q36941258 | Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway. |
| Q34698624 | Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine |
| Q47248578 | Organ-specific lymphatic vasculature: From development to pathophysiology. |
| Q93062687 | PD-1 Blockade During Post-partum Involution Reactivates the Anti-tumor Response and Reduces Lymphatic Vessel Density |
| Q91793162 | Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer |
| Q50419857 | Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. |
| Q92988200 | Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy |
| Q92186667 | Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma |
| Q35859226 | Primary Tumor-Secreted Lymphangiogenic Factors Induce Pre-Metastatic Lymphvascular Niche Formation at Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma |
| Q92593028 | Prognostic Value of Lymphovascular Invasion in Patients with Stage III Colorectal Cancer: A Retrospective Study |
| Q60961858 | Prognostic significance of the degree of lymphatic vessel invasion in locally advanced, surgically resectable pancreatic head cancer: A single center experience |
| Q51180773 | Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis. |
| Q92024932 | Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer |
| Q36544139 | RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma |
| Q58756849 | Recent advances in understanding the complexities of metastasis |
| Q30300970 | Regulation of T-cell Tolerance by Lymphatic Endothelial Cells. |
| Q90049366 | Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis |
| Q37404693 | Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent |
| Q40746522 | Retrograde Lymphatic Spread of Esophageal Cancer: A Case Report |
| Q99561631 | Risk factors of lobar lymph node metastases in non-primary tumor-bearing lobes among the patients of non-small-cell lung cancer |
| Q48355741 | S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β. |
| Q54095228 | Somatic mutations and increased lymphangiogenesis observed in a rare case of intramucosal gastric carcinoma with lymph node metastasis. |
| Q91429973 | Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancer |
| Q50665340 | Sphingosine-1-phosphate/sphingosine kinase 1-dependent lymph node metastasis in esophageal squamous cell carcinoma. |
| Q93062858 | Spz/Toll-6 signal guides organotropic metastasis in Drosophila |
| Q26752653 | Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells |
| Q36710907 | TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer |
| Q64274340 | Targeting Lymph Node Sinus Macrophages to Inhibit Lymph Node Metastasis |
| Q93333190 | The Multiple Layers of the Tumor Environment |
| Q47994440 | The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma |
| Q38689578 | The lymphatic system and pancreatic cancer |
| Q42427746 | The lymphatic vasculature revisited |
| Q35458865 | The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport |
| Q42316995 | The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis |
| Q90319382 | The prognostic role of angiolymphatic invasion in N0 esophageal carcinoma: a meta-analysis and systematic review |
| Q37709389 | The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and meta-analysis |
| Q42700855 | Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway |
| Q37166760 | Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice |
| Q35866159 | Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years). |
| Q47678837 | Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. |
| Q37197484 | Tumor-induced stromal reprogramming drives lymph node transformation |
| Q58796110 | Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread |
| Q90100757 | Use of a Lymphatic Drug Delivery System and Sonoporation to Target Malignant Metastatic Breast Cancer Cells Proliferating in the Marginal Sinuses |
| Q93040523 | Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation |
| Q64975690 | VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease. |
| Q64245258 | VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness |
| Q100694552 | VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells |
| Q38704616 | Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. |
| Q94517923 | circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer |
| Q64926349 | lncRNA ZEB1-AS1 promotes migration and metastasis of bladder cancer cells by post-transcriptional activation of ZEB1. |
| Q59792569 | uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis |
Search more.